Has Mary Hill received payments from drug or device companies?

Yes. Drug and device makers reported $4,846 in general payments to Mary Hill across 233 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mary Hill did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mary Hill come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mary Hill

Psychiatric/Mental Health · Houston, TXNPI 1982087581

Payments from drug & device makers

$4,846in general payments, 2019–2025

Across 233 payments — averaging $20.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Neurocrine Biosciences, Inc.$577
Johnson & Johnson$575
Otsuka America Pharmaceutical, Inc.$435
Supernus Pharmaceuticals, Inc.$434
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$343
Alkermes, Inc.$318
plus $2K from 17 others

What the payments were for

Food & beverage$4,838100%
Education$90%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Neurocrine Biosciences, Inc.	17	$577
Johnson & Johnson	26	$575
Otsuka America Pharmaceutical, Inc.	19	$435
Supernus Pharmaceuticals, Inc.	34	$434
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	12	$343
Alkermes, Inc.	14	$318
Corium, LLC	17	$294
Ironshore Pharmaceuticals Inc.	12	$225
AbbVie	12	$219
Takeda Pharmaceuticals U.S.A., Inc.	9	$188
Teva Pharmaceuticals USA, Inc.	9	$167
Lundbeck LLC	9	$157
Convatec Inc.	1	$154
Vanda Pharmaceuticals Inc.	8	$131
E.r. Squibb & Sons, L.L.C.	1	$129
Sunovion Pharmaceuticals Inc.	12	$123
Tris Pharma Inc	4	$77
Axsome Therapeutics, Inc.	4	$73
Neos Therapeutics, LP	4	$60
Indivior Inc.	2	$47
OWP Pharmaceuticals, Inc.	2	$45
Idorsia Pharmaceuticals US Inc	3	$41
Eisai Inc.	2	$33

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,846 in reported general payments places this provider in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Mirtazapine	11	$81

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Houston

Natalie TellezHouston$602K
Britney PridgenHouston$57K
Linzi LeightonHouston$16K
Samantha SharpeHouston$14K
Jennifer RobinsonHouston$12K
Tracy HicksLongview$684K
Karah BrashierRichardson$567K
Grant DavisRichardson$360K
Victor IlogEl Paso$167K
Lisa ShamblinGrapevine$163K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →